Publicacións en colaboración con investigadores/as de Fundación Jiménez Díaz (34)

2024

  1. Colchicine in acute heart failure: Rationale and design of a randomized double-blind placebo-controlled trial (COLICA)

    European Journal of Heart Failure, Vol. 26, Núm. 9, pp. 1999-2007

  2. Colchicine in acutely decompensated heart failure: the COLICA trial

    European Heart Journal, Vol. 45, Núm. 45, pp. 4826-4836

2022

  1. CIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiative

    Clinical genetics, Vol. 101, Núm. 5-6, pp. 481-493

  2. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up

    European Heart Journal, Vol. 43, Núm. 11, pp. 1059-1103

  3. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis

    Cardiovascular research, Vol. 118, Núm. 6, pp. 1385-1412

  4. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis

    European Heart Journal, Vol. 43, Núm. 11, pp. 1033-1058

2021

  1. Effect of COMBinAtion therapy with remote ischemic conditioning and exenatide on the Myocardial Infarct size: a two-by-two factorial randomized trial (COMBAT-MI)

    Basic Research in Cardiology, Vol. 116, Núm. 1

2020

  1. New insights into endogenous mechanisms of protection against arterial calcification

    Atherosclerosis, Vol. 306, pp. 68-74

  2. Spanish Cell Therapy Network (TerCel): 15 years of successful collaborative translational research

    Cytotherapy, Vol. 22, Núm. 1, pp. 1-5

2019

  1. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628

  2. Impact of acetate- or citrate-acidified bicarbonate dialysate on ex vivo aorta wall calcification

    Scientific Reports, Vol. 9, Núm. 1

  3. The role of sodium phosphate cotransporters in ectopic calcification

    Endokrynologia Polska, Vol. 70, Núm. 6, pp. 496-503

  4. Tissue non-specific alkaline phosphatase and vascular calcification: A potential therapeutic target

    Current Cardiology Reviews, Vol. 15, Núm. 2, pp. 91-95

2018

  1. Hydrolysis of Extracellular Pyrophosphate increases in post-hemodialysis plasma

    Scientific Reports, Vol. 8, Núm. 1

  2. Long-term prognosis of patients with life-threatening ventricular arrhythmias induced by coronary artery spasm

    Europace, Vol. 20, Núm. 5, pp. 851-858

  3. Pyrophosphate deficiency in vascular calcification

    Kidney International, Vol. 93, Núm. 6, pp. 1293-1297

  4. Role of pyrophosphate in vascular calcification in chronic kidney disease

    Nefrologia

  5. Synthesis of extracellular pyrophosphate increases in vascular smooth muscle cells during phosphate-induced calcification

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 38, Núm. 9, pp. 2137-2147

2017

  1. A decrease in intact parathyroid hormone (iPTH) levels is associated with higher mortality in prevalent hemodialysis patients

    PLoS ONE, Vol. 12, Núm. 3

  2. Differences between 2nd and 3rd generation seric parathormone determination methods on mortality in haemodialysis patients

    Nefrologia, Vol. 37, Núm. 4, pp. 389-396